Abstract 3420: DoE-based optimization of transposon-based gene insertion using the Harbor-IN system

Abstract Efficient and safe genetic labeling of mammalian cells is essential for applications in cell tracking, functional assays, and high-throughput screening. In this study, we developed and optimized a biosafety level 1 (BSL-1) protocol for stable integration of fluorescent and luminescent reporter genes using a transposon-based system. A Design of Experiments (DoE) approach was employed to systematically optimize co-transfection conditions of plasmid DNA encoding the reporter gene and in vitro-transcribed RNA encoding the transposase. Four commonly used transfection reagents—Lipofectamine 3000, PEI, ViaFect, and jetPRIME—were evaluated for their efficiency and compatibility with the system. Key factors such as nucleic acid ratios, total cargo amount, and reagent concentration were varied to maximize integration efficiency while maintaining cell viability. The optimized protocol achieved robust and reproducible reporter expression across multiple cell types without requiring viral vectors or higher biosafety containment. This work provides a scalable, non-viral strategy for generating stably labeled cell populations, enabling downstream applications in imaging, functional genomics, and assay development under standard laboratory conditions. Citation Format: Kanstantsin Lashuk, Corey Brizzee, Ina Rohleff, Julia B. Schueler. DoE-based optimization of transposon-based gene insertion using the Harbor-IN system [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3420.